Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL

Leukemia volume 17, pages 133–137 (2003)Cite this article

Abstract

In B-CLL IgVH genes mutational status is a major prognostic factor. Since sequencing of IgVH genes is not available in most laboratories, an easily performed surrogate assay is desirable. To identify the best surrogate assay, and to better discriminate prognostic subgroups we analyzed clinical and biological data from 58 typical CLL cases. A higher serum thymidine kinase level (>15 U/l) proved to be a strong predictor of mutational status, and the only independent one among the studied parameters. To further identify prognostic subgroups, cluster analysis was employed on 38 cases on which all data were available, which segregated two groups including 25 and 13 patients, respectively. These two clusters differed by their proliferative potential and appeared to discriminate patients with very different clinical course and outcome. s-TK was strikingly different among these two clusters, suggesting that s-TK level could be used routinely to identify patients at risk of progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Schroeder, HW Jr & Dighiero, G The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today, (1994). 15, 288–294.

    Article  CAS  PubMed  Google Scholar 

  2. Fais, F, Ghiotto, F, Hashimoto, S, Sellars, B, Valetto, A, Allen, SL, Schulman, P, Vinciguerra, VP, Rai, K, Rassenti, LZ, Kipps, TJ, Dighiero, G, Schroeder, HW Jr, Ferrarini, M & Chiorazzi, N Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest, (1998). 102, 1515–1525.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Hamblin, TJ, Davis, Z, Gardiner, A, Oscier, DG & Stevenson, FK Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, (1999). 94, 1848–1854.

    CAS  PubMed  Google Scholar 

  4. Maloum, K, Davi, F, Merle-Beral, H, Pritsch, O, Magnac, C, Vuillier, F, Dighiero, G, Troussard, X, Mauro, FF & Benichou, J Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia. Blood, (2000). 96, 377–379.

    CAS  PubMed  Google Scholar 

  5. Damle, RN, Wasil, T, Fais, F, Ghiotto, F, Valetto, A, Allen, SL, Buchbinder, A, Budman, D, Dittmar, K, Kolitz, J, Lichtman, SM, Schulman, P, Vinciguerra, VP, Rai, KR, Ferrarini, M & Chiorazzi, N Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, (1999). 94, 1840–1847.

    CAS  PubMed  Google Scholar 

  6. Hamblin, TJ, Orchard, JA, Gardiner, A, Oscier, DG, Davis, Z & Stevenson, FK Immunoglobulin V genes and CD38 expression in CLL. Blood, (2000). 95, 2455–2457.

    CAS  PubMed  Google Scholar 

  7. Matrai, Z, Lin, K, Dennis, M, Sherrington, P, Zuzel, M, Pettitt, AR & Cawley, JC CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia. Blood, (2001). 97, 1902–1903.

    Article  CAS  PubMed  Google Scholar 

  8. Thunberg, U, Johnson, A, Roos, G, Thorn, I, Tobin, G, Sallstrom, J, Sundstrom, C & Rosenquist, R CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia. Blood, (2001). 97, 1892–1894.

    Article  CAS  PubMed  Google Scholar 

  9. Di Raimondo, F, Giustolisi, R, Lerner, S, Cacciola, E, O’Brien, S, Kantarjian, H & Keating, MJ Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine. Ann Oncol, (2001). 12, 621–625.

    Article  CAS  PubMed  Google Scholar 

  10. Hallek, M, Langenmayer, I, Nerl, C, Knauf, W, Dietzfelbinger, H, Adorf, D, Ostwald, M, Busch, R, Kuhn-Hallek, I, Thiel, E & Emmerich, B Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia. Blood, (1999). 93, 1732–1737.

    CAS  PubMed  Google Scholar 

  11. Vrhovac, R, Delmer, A, Tang, R, Marie, JP, Zittoun, R & Ajchenbaum-Cymbalista, F Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic B-cell lymphocytic leukemia. Blood, (1998). 91, 4694–4700.

    CAS  PubMed  Google Scholar 

  12. Levy, V, Nataf, J, Zompi, S, Thomas, F, Brouzes, C, Casadevall, N, Hallek, M, Delmer, A & Ajchenbaum-Cymbalista, F Prognostic significance of serum thymidine kinase levels and p27KIP1 expression in chronic lymphocytic leukemia. Blood, (1999). 94, 321a

    Google Scholar 

  13. Pritsch, O, Troussard, X, Magnac, C, Mauro, FR, Davi, F, Payelle-Brogard, B, Dumas, G, Pulik, M, Clerget, F, Mandelli, F, Chiorazzi, N, Schroeder, HW Jr, Leporrier, M & Dighiero, G VH gene usage by family members affected with chronic lymphocytic leukaemia. Br J Haematol, (1999). 107, 616–624.

    Article  CAS  PubMed  Google Scholar 

  14. Everitt, BS Cluster analysis of subjects. Non hierarchical methods. In: Armitage P, Colton T (eds). Encyclopedia of Biostatistics, John Wiley and Sons: Chichester (1998). 713–731.

    Google Scholar 

  15. Efron, B & Tibshirani, R An Introduction to Bootstrap, Chapman & Hall: London (1993).

    Book  Google Scholar 

  16. Delmer, A, Ajchenbaum-Cymbalista, F, Tang, R, Ramond, S, Faussat, AM, Marie, JP & Zittoun, R Overexpression of cyclin D2 in chronic B-cell malignancies. Blood, (1995). 85, 2870–2876.

    CAS  PubMed  Google Scholar 

  17. Solvason, N, Wu, WW, Parry, D, Mahony, D, Lam, EW, Glassford, J, Klaus, GG, Sicinski, P, Weinberg, R, Liu, YJ, Howard, M & Lees, E Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development. Int Immunol, (2000). 12, 631–638.

    Article  CAS  PubMed  Google Scholar 

  18. Sanchez-Beato, M, Saez, AI, Martinez-Montero, JC, Sol Mateo, M, Sanchez-Verde, L, Villuendas, R, Troncone, G & Piris, MA Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index. Am J Pathol, (1997). 151, 151–160.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Meyyappan, M, Wong, H, Hull, C & Riabowol, KT Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells. Mol Cell Biol, (1998). 18, 3163–3172.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Dighiero, G, Maloum, K, Desablens, B, Cazin, B, Navarro, M, Leblay, R, Leporrier, M, Jaubert, J, Lepeu, G, Dreyfus, B, Binet, JL & Travade, P Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia. N Engl J Med, (1998). 338, 1506–1514.

    Article  CAS  PubMed  Google Scholar 

  21. Leporrier, M, Chevret, S, Cazin, B, Boudjerra, N, Feugier, P, Desablens, B, Rapp, MJ, Jaubert, J, Autrand, C, Divine, M, Dreyfus, B, Maloum, K, Travade, P, Dighiero, G, Binet, JL & Chastang, C Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. Blood, (2001). 98, 2319–2325.

    Article  CAS  PubMed  Google Scholar 

  22. Betensky, R, Louis, N & Cairncross, J Influence of unrecognized molecular heterogeneity on randomized clinical trials. J Clin Oncol, (2002). 20, 2495–2499.

    Article  PubMed  Google Scholar 

  23. Rosenwald, A, Alizadeh, AA, Widhopf, G, Simon, R, Davis, RE, Yu, X, Yang, L, Pickeral, OK, Rassenti, LZ, Powell, J, Botstein, D, Byrd, JC, Grever, MR, Cheson, BD, Chiorazzi, N, Wilson, WH, Kipps, TJ, Brown, PO & Staudt, LM Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med, (2001). 194, 1639–1647.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Klein, U, Tu, Y, Stolovitzky, GA, Mattioli, M, Cattoretti, G, Husson, H, Freedman, A, Inghirami, G, Cro, L, Baldini, L, Neri, A, Califano, A & Dalla-Favera, R Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med, (2001). 194, 1625–1638.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut Pasteur, Paris, France

    C Magnac, B Payelle-Brogard, P Oppezzo & G Dighiero

  2. DBIM Hôpital Saint-Louis, INSERM U 444, Paris, France

    R Porcher & V Lévy

  3. Hematology Department, Hôpital de la Pitié, Paris, France

    F Davi

  4. Hematology Department Hotel-Dieu, APHP, Paris, France

    J Nataf, R P Tang & F Ajchenbaum-Cymbalista

Authors
  1. C Magnac
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R Porcher
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F Davi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J Nataf
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B Payelle-Brogard
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R P Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P Oppezzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. V Lévy
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G Dighiero
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. F Ajchenbaum-Cymbalista
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Magnac, C., Porcher, R., Davi, F. et al. Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL. Leukemia 17, 133–137 (2003). https://doi.org/10.1038/sj.leu.2402780

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402780

Keywords

This article is cited by

Search

Advanced search

Quick links